A patient on Armour Thyroid (desiccated thyroid) 90 µg has a TSH of 6.3 mIU/L, total T3 of 275 ng/dL, and free T4 of 0.99 ng/dL; what dose adjustment or management recommendations are appropriate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Increase the Armour Thyroid dose to normalize the elevated TSH

Your patient's TSH of 6.3 mIU/L indicates inadequate thyroid hormone replacement, and the dose should be increased. The current 90 mg dose is insufficient, as evidenced by the elevated TSH above the normal reference range.

Dosing Adjustment Strategy

According to the FDA label for Armour Thyroid, most patients require 60 to 120 mg/day for maintenance, and your patient is at the lower end of this range 1. Given the TSH of 6.3 mIU/L:

  • Increase the dose by 15 mg increments every 2-3 weeks until TSH normalizes 1
  • Start by increasing from 90 mg to 105 mg daily
  • Recheck TSH, free T4, and free T3 in 4-8 weeks after each adjustment 2
  • Continue titrating until TSH reaches the normal reference range (typically 0.4-4.0 mIU/L)

Interpreting the Current Labs

The free T4 of 0.99 ng/dL appears relatively normal (assuming reference range ~0.8-1.8 ng/dL), while the total T3 of 275 ng/dL is elevated (normal range typically 80-200 ng/dL). This pattern is characteristic of desiccated thyroid preparations, which contain a 4:1 ratio of T4 to T3 by weight 2. This creates higher T3 levels relative to T4 compared to levothyroxine monotherapy 3, 4.

Key point: Despite the elevated T3, the TSH remains high, indicating the overall thyroid hormone effect is insufficient. The TSH is the primary guide for dose adjustment in primary hypothyroidism 5, 2.

Important Caveats

Age and Cardiac Considerations

  • If the patient is over 50-60 years old or has any cardiac history, increase doses more cautiously (12.5 mg increments) and monitor for anginal symptoms 2
  • The appearance of angina is an indication to reduce the dose 1

Compliance and Absorption Issues

Before increasing the dose, verify:

  • Medication timing: Armour Thyroid should be taken 30-60 minutes before breakfast on an empty stomach for optimal absorption 2
  • Interfering substances: Avoid taking with calcium, iron, proton pump inhibitors, or other medications that impair absorption 2
  • Patient compliance: Failure to respond to doses of 180 mg suggests non-compliance or malabsorption 1

Monitoring Timeline

  • Recheck labs 4-8 weeks after each dose change 2
  • TSH may take 8 weeks or longer to plateau with smaller dose adjustments 2
  • Once stable, monitor TSH every 6-12 months 2

Alternative Consideration

While guidelines recommend levothyroxine (T4) monotherapy as first-line treatment 2, if the patient specifically prefers or has been doing well on desiccated thyroid aside from the elevated TSH, continuing with dose optimization is reasonable. The elevated T3 levels seen with desiccated thyroid are expected and generally well-tolerated 6, 7, though long-term cardiovascular safety data remain limited 6.

The goal is to normalize TSH to the reference range while maintaining the patient symptom-free 5, 2. Most patients on Armour Thyroid achieve normal TSH and T4 levels with maintenance doses of 60-120 mg/day 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.